Thyroid Eye Disease
📧 Sign up to get email alerts when something new happens for Thyroid Eye Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-26Clinical Trial Results: A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) [Phase 2, Phase 3]
Phase 2b/Phase 3 clinical trial results for linsitinib in active moderate to severe thyroid eye disease (Graves orbitopathy).
-
CLINICAL_TRIALS trial_result · 2026-08-18Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial update for VRDN-003 in active thyroid eye disease (TED) focusing on efficacy, safety, and tolerability.
-
CLINICAL_TRIALS trial_result · 2026-08-14Clinical Trial Results: An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301 [Phase 3]
Phase 3 open-label study results for non-responders to VRDN-001-101 and VRDN-001-301 in Thyroid Eye Disease have been completed with results…
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial results for VRDN-001 in thyroid eye disease have been completed with safety and tolerability reported.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial results for Veligrotug (VRDN 001) in thyroid eye disease have been completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-08-13Clinical Trial Results: An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) [Phase 3]
Phase 3 trial results for Veligrotug (VRDN-001) in chronic thyroid eye disease evaluated efficacy, safety, and tolerability; study completed…
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Results: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
Phase 3 trial evaluating satralizumab for efficacy and safety in thyroid eye disease completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-08-12Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
Phase 3 trial update for satralizumab in thyroid eye disease; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Results: Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
Phase 3 trial evaluating satralizumab for thyroid eye disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-31Clinical Trial Update: Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease [Phase 3]
A Phase 3 trial evaluating satralizumab for thyroid eye disease has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2026-06-25Clinical Trial Update: A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) [Phase 3]
Phase 3 clinical trial update reporting safety, tolerability, and pharmacokinetics of VRDN-003 in participants with Thyroid Eye Disease; stu…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye Disease [Phase 2]
Phase 2 clinical trial update for TOUR006 evaluating efficacy and safety in adults with Thyroid Eye Disease; the study is currently ACTIVE_N…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease [Phase 2]
Phase 2 clinical trial update on tofacitinib for glucocorticoid-resistant moderate-to-severe Thyroid Eye Disease; the study is currently act…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease [Phase 1]
This is a Phase 1 clinical trial investigating Lu AG22515 in adults with moderate-to-severe Thyroid Eye Disease; the study status is active …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED) [Phase 3]
Clinical trial update for VRDN-003 in active Thyroid Eye Disease; the Phase 3 study is ongoing but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease [Phase 1, Phase 2]
AMG 732 is being studied in healthy participants and individuals with Thyroid Eye Disease in Phase 1/2 trials, and the study is currently re…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) [Phase 3]
This update notes a Phase 3 safety and tolerability trial of VRDN-003 in Thyroid Eye Disease. The study is currently active and not recruiti…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease [Phase 2]
Open-label rollover Phase 2 trial evaluating the efficacy and safety of AMG 732 in participants with Thyroid Eye Disease; the study status i…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Study to Assess Batoclimab in Participants With Active Thyroid Eye Disease [Phase 3]
A Phase 3 trial evaluating batoclimab for active Thyroid Eye Disease has completed.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Evaluation of K9 in Subjects With Thyroid Eye Disease (TED) [Phase 1]
The Phase 1 trial evaluating K9 in subjects with Thyroid Eye Disease has been terminated. No phase 1 results are reported in this update.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: MHB018A Treatment in Patients With Chronic Thyroid Eye Disease [Phase 3]
This clinical trial update indicates that the Phase 3 study of MHB018A for chronic thyroid eye disease is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease [Phase 3]
An ongoing Phase 3 open-label extension trial evaluating MHB018A in people with Thyroid Eye Disease, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting
Clinical trial from Imperial College London evaluating the pharmacokinetics of high-dose prednisolone in acute and chronic inflammatory sett…
-
CLINICAL_TRIALS other · 2026-03-18Clinical Trial Update: Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease [NA]
This clinical trial update describes a study evaluating statin plus vitamin D treatment in patients with Thyroid Eye Disease (Graves' ophtha…
-
CLINICAL_TRIALS trial_result · 2026-03-16Clinical Trial Update: A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease [Phase 3]
A Phase 3 study of subcutaneously administered efgartigimod for Thyroid Eye Disease has been terminated.